Published in AIDS Weekly, May 23rd, 2005
"I am very excited about the positive results we have seen in this study. These results allow us to move forward in planning our phase 3 pivotal program for NSCLC, which we intend to initiate later this year," said Dr. Maggie Uprichard, senior vice president and chief development officer at Point.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.